Conditions: Alzheimer's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 144
Healthy volunteers: no

Brief summary:
The purpose of this study is to test the efficacy and safety of an investigational medication for improving symptoms of Alzheimer's Disease. Subjects will receive either active medication or placebo for 28 days. Tests of memory, concentration will be included. Safety will be monitored using routine clinical and laboratory tests.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MK0249 intervention 2: Comparator: Placebo (unspecified)
Intervention descriptions: intervention 1: MK0249 two (2) 2.5 mg capsules quaque die (qd) for 28 day treatment period. intervention 2: MK0249 two (2) 2.5 mg Pbo capsules qd for a 28 day treatment period

Protocol document: